Cargando…

Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria

The mainstay of phenylketonuria treatment is a low protein diet, supplemented with phenylalanine (Phe)-free protein substitutes and micronutrients. Adhering to this diet is challenging, and even patients with good metabolic control who follow the dietary prescriptions in everyday life ignore the rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Scala, Iris, Concolino, Daniela, Nastasi, Anna, Esposito, Giulia, Crisci, Daniela, Sestito, Simona, Ferraro, Stefania, Albano, Lucia, Ruoppolo, Margherita, Parenti, Giancarlo, Strisciuglio, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618154/
https://www.ncbi.nlm.nih.gov/pubmed/34836270
http://dx.doi.org/10.3390/nu13114012
_version_ 1784604679243563008
author Scala, Iris
Concolino, Daniela
Nastasi, Anna
Esposito, Giulia
Crisci, Daniela
Sestito, Simona
Ferraro, Stefania
Albano, Lucia
Ruoppolo, Margherita
Parenti, Giancarlo
Strisciuglio, Pietro
author_facet Scala, Iris
Concolino, Daniela
Nastasi, Anna
Esposito, Giulia
Crisci, Daniela
Sestito, Simona
Ferraro, Stefania
Albano, Lucia
Ruoppolo, Margherita
Parenti, Giancarlo
Strisciuglio, Pietro
author_sort Scala, Iris
collection PubMed
description The mainstay of phenylketonuria treatment is a low protein diet, supplemented with phenylalanine (Phe)-free protein substitutes and micronutrients. Adhering to this diet is challenging, and even patients with good metabolic control who follow the dietary prescriptions in everyday life ignore the recommendations occasionally. The present study explores the ability of slow-release large neutral amino acids (srLNAAs) to prevent Phe increase following a Phe dietary load. Fourteen phenylketonuric patients aged ≥13 years were enrolled in a 6-week protocol. Oral acute Phe loads of 250 and 500 mg were added to the evening meal together with srLNAAs (0.5 gr/kg). Phe and tyrosine were dosed before dinner, 2h-after dinner, and after the overnight fast. After oral Phe loads, mean plasma Phe remained stable and below 600 µmol/L. No Phe peaks were registered. Tyrosine levels significantly increased, and Phe/Tyrosine ratio decreased. No adverse events were registered. In conclusion, a single oral administration of srLNAAs at the dose of 0.5 gr/kg is effective in maintaining stable plasma Phe during acute oral loads with Phe-containing food and may be added to the dietetic scheme in situations in which patients with generally good adherence to diet foresee a higher than prescribed Phe intake due to their commitments.
format Online
Article
Text
id pubmed-8618154
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86181542021-11-27 Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria Scala, Iris Concolino, Daniela Nastasi, Anna Esposito, Giulia Crisci, Daniela Sestito, Simona Ferraro, Stefania Albano, Lucia Ruoppolo, Margherita Parenti, Giancarlo Strisciuglio, Pietro Nutrients Article The mainstay of phenylketonuria treatment is a low protein diet, supplemented with phenylalanine (Phe)-free protein substitutes and micronutrients. Adhering to this diet is challenging, and even patients with good metabolic control who follow the dietary prescriptions in everyday life ignore the recommendations occasionally. The present study explores the ability of slow-release large neutral amino acids (srLNAAs) to prevent Phe increase following a Phe dietary load. Fourteen phenylketonuric patients aged ≥13 years were enrolled in a 6-week protocol. Oral acute Phe loads of 250 and 500 mg were added to the evening meal together with srLNAAs (0.5 gr/kg). Phe and tyrosine were dosed before dinner, 2h-after dinner, and after the overnight fast. After oral Phe loads, mean plasma Phe remained stable and below 600 µmol/L. No Phe peaks were registered. Tyrosine levels significantly increased, and Phe/Tyrosine ratio decreased. No adverse events were registered. In conclusion, a single oral administration of srLNAAs at the dose of 0.5 gr/kg is effective in maintaining stable plasma Phe during acute oral loads with Phe-containing food and may be added to the dietetic scheme in situations in which patients with generally good adherence to diet foresee a higher than prescribed Phe intake due to their commitments. MDPI 2021-11-10 /pmc/articles/PMC8618154/ /pubmed/34836270 http://dx.doi.org/10.3390/nu13114012 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Scala, Iris
Concolino, Daniela
Nastasi, Anna
Esposito, Giulia
Crisci, Daniela
Sestito, Simona
Ferraro, Stefania
Albano, Lucia
Ruoppolo, Margherita
Parenti, Giancarlo
Strisciuglio, Pietro
Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
title Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
title_full Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
title_fullStr Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
title_full_unstemmed Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
title_short Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
title_sort beneficial effects of slow-release large neutral amino acids after a phenylalanine oral load in patients with phenylketonuria
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618154/
https://www.ncbi.nlm.nih.gov/pubmed/34836270
http://dx.doi.org/10.3390/nu13114012
work_keys_str_mv AT scalairis beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT concolinodaniela beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT nastasianna beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT espositogiulia beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT criscidaniela beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT sestitosimona beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT ferrarostefania beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT albanolucia beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT ruoppolomargherita beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT parentigiancarlo beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria
AT strisciugliopietro beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria